| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 14 |
| 1 | RIVAROXABAN | 14 |
| 2 | MYCOPHENOLATE MOFETIL | 13 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 13 |
| 4 | ASPIRIN | 11 |
| 5 | ECULIZUMAB | 11 |
| 6 | ASPIRIN 325 MG | 10 |
| 7 | ASPIRIN 81 MG | 10 |
| 8 | DEXAMETHASONE | 9 |
| 9 | DEXAMETHASONE 1.5 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | CAMPHOR, CAPSAICIN, MENTHOL | 1 | 0.0019 |
| 2 | MENTHOL, UNSPECIFIED FORM | 1 | 0.0016 |
| 3 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 5 | OMAVELOXOLONE | 2 | 0.0011 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0011 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| 8 | OXYTOCIN | 3 | 0.0010 |
| 9 | CHOLESTERINUM | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Factor Xa Inhibitor [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Complement Inhibitor [EPC] | 12 |
| 4 | beta-Adrenergic Blocker [EPC] | 12 |
| 5 | Janus Kinase Inhibitor [EPC] | 11 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 7 | Proton Pump Inhibitor [EPC] | 11 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 8 |
| 9 | Kinase Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 3 | 0.0010 |
| 1 | Vitamin K [EPC] | 6 | 0.0007 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 8 | 0.0002 |
| 4 | Complement Inhibitor [EPC] | 12 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 6 | Bismuth [EPC] | 1 | 0.0002 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |